PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
27355194-1	2016	The potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor NU6027 (6-cyclohexylmethoxy-5-nitroso-2,4-diaminopyrimidine) was used as the lead for the synthesis of a series of analogues in order to provide further insight into the structure-activity relationships for 2,4-diaminopyrimidine CDK2 inhibitors.	6-cyclohexylmethoxy-5-nitroso-2,4-diaminopyrimidine	76-127	cyclin dependent kinase 2	Homo sapiens	25-50
27355194-1	2016	The potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor NU6027 (6-cyclohexylmethoxy-5-nitroso-2,4-diaminopyrimidine) was used as the lead for the synthesis of a series of analogues in order to provide further insight into the structure-activity relationships for 2,4-diaminopyrimidine CDK2 inhibitors.	6-cyclohexylmethoxy-5-nitroso-2,4-diaminopyrimidine	76-127	cyclin dependent kinase 2	Homo sapiens	52-56
27355194-1	2016	The potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor NU6027 (6-cyclohexylmethoxy-5-nitroso-2,4-diaminopyrimidine) was used as the lead for the synthesis of a series of analogues in order to provide further insight into the structure-activity relationships for 2,4-diaminopyrimidine CDK2 inhibitors.	6-cyclohexylmethoxy-5-nitroso-2,4-diaminopyrimidine	76-127	cyclin dependent kinase 2	Homo sapiens	297-301